THE HALFAX HEIMDALL AUGUR

Centre Bans 16 Fixed-Dose Combination Drugs After Safety Review, Cites ... The Government of India has imposed an immediate nationwide ban on 16 fixed-dose combination (FDC) medicines following a detailed scientific review that found the formulations lacked medical justification for continued use. The decision was notified under Section 26A of the Drugs and Cosmetics Act, 1940. In its official announcement, the Union Health Ministry stated that the “manufacture for sale, sale, distribution and supply” of the identified 16 FDCs for human use has been prohibited with immediate effect across the country. The banned drugs span several therapeutic categories, including antibiotics, pain management combinations, antispasmodic drugs, and dermatological formulations. Among the prohibited combinations are drugs such as Acetyl Salicylic Acid with Ethoheptazine; combinations of Dicyclomine, Paracetamol and Clidinium Bromide; and multi-drug formulations including Dicyclomine, Paracetamol, Clidinium Bromide and Chlordiazepoxide. Other restricted products include Gliclazide with Chromium Picolinate and Paracetamol with Lignocaine. The order also targets multiple antibiotic combinations, includi…

Government bans 16 fixed-dose drug combinations: Here's the list The Indian government has banned 16 popular drug combinations, deeming them therapeutically unjustified and potentially risky. This decisive action by the Union Health Ministry aims to protect public health and ensure only effective, scientifically validated medicines reach consumers. The prohibited formulations cover pain relief, muscle relaxation, diabetes management, and antibiotic categories, including several widely used antibiotic mixes and certain skincare products.

Government Bans 16 Common Combination Drugs Over Safety Concerns: Full ... In a major move aimed at improving patient safety and promoting evidence-based healthcare, the Union Health Ministry has banned the manufacture, sale, distribution, and supply of 16 fixed-dose combination (FDC) drugs across India. The government said these medicines lack "therapeutic justification" and that their continued use poses potential health risks that outweigh any proven benefits. The decision comes after an extensive scientific review ordered under the directions of the Supreme Court and is part of India's ongoing efforts to eliminate irrational medicines from the market. Breaking It Down What are the risks associated with fixed-dose combination drugs? How did the government previously regulate FDCs? What is the role of the Drugs Technical Advisory Board (DTAB)? Created with AI. Errors are possible Also read: Rahul Gandhi Talks Jiu-Jitsu - Here's Why This Martial Art Is a Full-Body Health Booster What are fixed-dose combination (FDC) drugs? Fixed-dose combination (FDC) drugs are medicines that combine two or more active pharmaceutical ingredients (APIs) in a fixed ratio within a single tablet, cap…

Centre bans 16 fixed-dose drug combinations, citing public health concerns FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio

Government bans sale and manufacture of 35 fixed-dose ... Government Bans 35 Fixed-Dose Combination Drugs: Here’s Why It Matters In a significant move aimed at safeguarding public health, theCentral Drugs Standard Control Organisation (CDSCO), India’s apex drug regulatory authority, has officially banned the manufacture and sale of 35fixed-dose combination (FDC)drugs. These combinations, which include widely-used painkillers, nutritional supplements, fertility treatments, and anti-diabetic medications, were being sold without adequate scientific evaluation of their safety and efficacy. What Are Fixed-Dose Combination (FDC) Drugs? Fixed-dose combination drugs are pharmaceutical formulations that combine two or more active pharmaceutical ingredients (APIs) in a fixed ratio within a single dosage form. Often referred to as "cocktail medicines," they are intended to simplify treatment regimens. However, not all combinations are clinically justified. When such combinations are used without proper research or rationale, they can pose serious health risks due to adverse drug interactions or incorrect dosing. Why the Ban? The CDSCO’s decision was based on concerns over the irrational…

Centre bans 16 Fixed Dose Combination drugs over safety and efficacy ... Share: Copied Listen to Article Audio Loading voice… 0.85× 1× 1.15× 1.3× 1.5× Synopsis India's Health Ministry has immediately banned 16 Fixed Dose Combination drugs — spanning painkillers, antibiotics, and dermatological products — after a Supreme Court-directed expert review found them irrational and potentially harmful. It is the latest in a decade-long regulatory push to purge scientifically unjustified drug combinations from the Indian market. Key Takeaways The Ministry of Health and Family Welfare banned 16 Fixed Dose Combination (FDC) drugs with immediate effect on 20 June . The ban was imposed under Section 26A of the Drugs and Cosmetics Act, 1940 , following a Supreme Court directive for a comprehensive FDC review. The Drugs Technical Advisory Board (DTAB) Expert Committee found all 16 FDCs lacked adequate therapeutic justification and posed potential health risks. Affected categories include dermatological products , pain-relief and antispasmodic drugs , and antibiotic-based formulations . All State Drug Controllers , manufacturers, importers, and distributors have been directed to implement the ban…

Centre bans 16 Fixed-Dose Combination drugs over safety concerns The Centre has imposed an immediate ban on 16 Fixed Dose Combination (FDC) drugs. The Ministry of Health and Family Welfare issued the orders under Section 26A of the Drugs and Cosmetics Act, effectively halting the manufacture, sale and distribution of these medicines across India after a scientific review flagged them that the formulations lacked therapeutic justification and could pose risks to public health. This sweeping move branch from a Supreme Court-mandated review of the Indian drug market. Following the court’s orders, the Drugs Technical Advisory Board (DTAB) formed an expert committee to completely remobve potentially harmful formulations. After reviewing the clinical data, the panel concluded that these 16 specific combinations offered no real therapeutic value to patients, leading to their immediate prohibition. The banned combinations belong to different therapeutic categories, including dermatological preparations, pain-relief medicines, antispasmodic drugs, anti-diabetic formulations and antibiotic-based products. Among the combinations prohibited are formulations whuich contains amoxicillin and …

India Bans 35 Unapproved Fixed-Dose Combination Drugs ... Key Insights India's Central Drugs Standard Control Organisation (CDSCO) has directed all states and territories to halt the manufacture, sale, and distribution of 35 unapproved fixed-dose combination drugs that lack proper safety and efficacy evaluation. The banned combinations include various painkillers, nutrition supplements, and anti-diabetic medications that were licensed by state authorities without required central approval, posing significant public health risks. Drugs Controller General of India Dr. Rajeev Raghuvanshi has ordered state regulators to review their approval processes and ensure strict compliance with the Drugs and Cosmetics Act 1940 and New Drugs and Clinical Trials Rules 2019. India's apex drug regulatory body has taken decisive action against potentially harmful pharmaceutical combinations by ordering an immediate ban on 35 fixed-dose combination Search drug (FDC) drugs that were approved without proper safety evaluation. The Central Drugs Standard Control Organisation Search company (CDSCO) issued directives on April 11 to drug controllers across all Indian states and Union Territories to halt the…